Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
NCT ID: NCT06010550
Last Updated: 2023-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
600 participants
OBSERVATIONAL
2023-10-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of 3D Simulations in Embolic Stroke
NCT05055960
Validation of TriAGE+ for Predicting Stroke Risk in ED Patients Presenting With Dizziness
NCT06641050
Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
NCT05865795
A Novel Score to Predict Risk of Symptomatic Intracerebral Hemorrhage
NCT04554368
Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia
NCT06069973
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dizziness/vertigo
Patients aged 20 or above, presenting to the emergency department with dizziness or vertigo.
Magnetic resonance imaging
Brain magnetic resonance imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic resonance imaging
Brain magnetic resonance imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged ≥ 20
* Dizziness or vertigo lasting for at least 1 hour and \< 7 days
* Persistent dizziness or vertigo at the time of the examination at the emergency department
Exclusion Criteria
* Having frank stroke-like symptoms or signs, such as hemiparesis, facial asymmetry, dysarthria, dysphasia, ataxia, gaze palsy
* Consciousness disturbance, Glasgow coma scale \< 13
* Severe dementia
* Recent stroke within 3 months
* Dizziness or vertigo thought to be the result of head injury, hypotension, medication/drug intoxication, hypoglycemia, electrolyte imbalance, anemia, hepatic encephalopathy, hydrocephalus, etc
* Concomitant head or neck trauma
* Severe degenerative cervical spondylosis
* Having contraindications to magnetic resonance imaging examination
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Science and Technology Council
FED
Chiayi Christian Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sheng-Feng Sung, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Ditmanson Medical Foundation Chia-Yi Christian Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB2023009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.